Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention

NCT01245725 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was not initiated, change in clinical development

Conditions

Myocardial Infarction
Acute Coronary Syndromes
Unstable Angina
Percutaneous Coronary Intervention

Interventions

DRUG: Tirofiban (Aggrastat)
DRUG: Placebo

Sponsor

Medicure

Collaborators

[object Object]